The Library
FX125L, a novel small molecule chemokine inhibitor, attenuates neutrophil accumulation in a model of allergic asthma and exhibits a superior efficacy profile to dexamethasone or monteleukast
Tools
Tools
Tools
Grainger, David J., Reckless, J., Piercy, V., Langley, K., Purvis, I., Purvis, I. and Fox, David J. (2009) FX125L, a novel small molecule chemokine inhibitor, attenuates neutrophil accumulation in a model of allergic asthma and exhibits a superior efficacy profile to dexamethasone or monteleukast. In: 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Warsaw, Poland, June 06-10, 2009. Published in: Allergy, Vol.64 (Suppl. 90). p. 539.
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1111/j.1398-9995.2009.02077.x
| Item Type: | Conference Item (Paper) |
|---|---|
| Subjects: | R Medicine > RA Public aspects of medicine Q Science > QR Microbiology > QR180 Immunology |
| Divisions: | Faculty of Science > Chemistry |
| Journal or Publication Title: | Allergy |
| Publisher: | Wiley-Blackwell Publishing Ltd. |
| ISSN: | 0105-4538 |
| Date: | 2009 |
| Volume: | Vol.64 |
| Number: | Suppl. 90 |
| Number of Pages: | 1 |
| Page Range: | p. 539 |
| Identification Number: | 10.1111/j.1398-9995.2009.02077.x |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| Conference Paper Type: | Paper |
| Title of Event: | 28th Congress of the European-Academy-of-Allergy-and-Clinical-Immunology |
| Type of Event: | Conference |
| Location of Event: | Warsaw, Poland |
| Date(s) of Event: | June 06-10, 2009 |
| URI: | http://wrap.warwick.ac.uk/id/eprint/27922 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
 |
View Item |
